Less than two year after going public by a SPAC merger, Gemini will reverse merge with hematology-focused Disc. Bristol Myers Squibb and GentiBio will join forces on Treg development for inflammatory bowel disorders.

An advertisement for a cranberry supplement which asked the question ‘Urinary tract infection?’ earned Italy's Sofar a slap on the wrist from the country's advertising regulator. The authority ruled that posing such a question was misleading consumers about the product's curative qualities.

The latest drug development news and highlights from our US FDA Performance Tracker.

With EpiPen injector patent-protected and patients accustomed to its use, finding a substitutable generic device may prove difficult.